Purdue withdraws plans to participate in FDA meeting on painkillers; Allscripts takes 10% stake in NantHealth in advance of IPO; union advocates to end pharma support for CME
With an eye on the bottom line, hospitals and their marketing firms traditionally haven't spent much time on school campuses.
Medscape marked its 20th anniversary with a reunion this week that attracted staffers from the portal's earliest days.
The legislation would allow drugmakers to share economic information with payers beyond what is included on the FDA-approved label.
The draft would allow drugmakers to share off-label economic data with payers, a practice that until now has been considered taboo, and require the FDA to assess patient experience data in regulatory decisions, in addition to boosting funding for the NIH.
Shire's ADHD treatment Vyvanse won a label expansion into treating moderate-to-severe binge-eating disorder (BED) Friday. One analyst says that disease awareness and detailing efforts are crucial to the drug's commercial plans in the category.
The artwork is meant to inspire debate and donations for vaccinations.
"We are living in an era of great medical technological innovations. However, this is shifting healthcare back home and expecting patients to understand excessive medical information and follow complex instructions."
CMS redefined the Sunshine CME exemption, still allowing most payments to go unreported.
The new initiative will look to recruit a teenager with epilepsy to appear in the next iteration of its educational comic book series.